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SCIATIC NERVE REMYELINATION AND NODAL FORMATION FOLLOWING 
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Department of Neurology and Center for Neuroscience and Regeneration Research, Yale 
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Transplantation of olfactory ensheathing cells (OECs) into injured spinal cord results 
in improved functional outcome through axonal regeneration, remyelination, and 
neuroprotection.  However, because little is known of the fate of OECs transplanted into 
injured peripheral nerve, their myelin forming potential requires investigation.  To study 
these issues OECs were isolated from the olfactory bulbs of adult green fluorescent protein 
(GFP)-expressing transgenic rats and transplanted into a sciatic nerve crush lesions.  Five 
weeks to six months after transplantation the nerves were studied histologically and it was 
determined that GFP-expressing OECs survived in the lesion and distributed longitudinally 
across the lesion zone.  Immunostaining revealed a high density of isoform Nav1.6 at the 
newly formed nodes of Ranvier which were flanked by paranodal Caspr staining.  Immuno-
electron microscopy for GFP revealed transplanted OECs form peripheral type myelin.  
These results indicate that transplanted OECs extensively integrate into transected peripheral 
nerve, form myelin on regenerated peripheral nerve fibers, and reconstruct nodes of Ranvier 
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Olfactory ensheathing cells (OECs) are specialized glial cells that guide the 
regeneration of nonmyelinated olfactory axons from the peripheral nasal epithelium, 
through the cribiform plate of the ethmoid bone, and into the olfactory bulb.  They are 
located in the olfactory epithelium, olfactory nerve, and the first two outer layers of the 
olfactory bulb known as the olfactory nerve layer (1).  The olfactory neuroepithelium 
undergoes continuous turnover and sends new axons into the olfactory bulb where they 
synapse with two cell types responsible for the output signals: mitral cells and tufted 
cells.  Mitral cells are a specific type of neuron that have a primary dendrite, as well as 
multiple branching dendrites.  Tufted cells are similar in structure to mitral cells; 
however, they have distinct projections into the olfactory cortex.  These cells also have 
distinct molecular phenotypes (2).    
Olfactory axons continuously regenerate throughout the lifetime of an organism, 
and they begin in the nasal epithelium as nonmyelinated, individual axons that form 
bundles.  These bundles, fila olfactoria, migrate from the periphery, cross the pia mater, 
and then enter the central nervous system (CNS) where they establish connections with 
neurons in the olfactory bulb (1).  More specifically, OECs accompany axons through the 
lamina propria in the peripheral nervous system (PNS) and into the CNS via the cribiform 
plate.  It is the OECs and their associated axons that surround the outside of the olfactory 
bulb and create the olfactory nerve layer (3).  The olfactory nerve layer is divided into 
two distinct layers before the olfactory axons continue, unaccompanied by the OECs, into 
the deeper layers of the olfactory bulb.  The two layers are termed the “outer” and “inner” 
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layer and differ in their molecular expression.  Thus, it is primarily the olfactory nerve 
layer that is rich in OECs and is the target for OEC collection.   
OECs surround olfactory axons throughout their segments in the PNS and in the 
olfactory bulb.  Specifically, they act to group the separate receptor axons into fascicles 
by creating cytoplasmic projections that encase the bundles (3).  Also, because the OECs 
surround the olfactory axons, they act to prevent the axons from coming into contact with 
other types of glial cells.  This is a major reason why OECs are thought to play a critical 
role in guiding the regrowth of olfactory neurons (4).   
The developmental origin of the olfactory system gives clues about the 
characteristics and function of OECs.  Within the olfactory nerve and olfactory bulb there 
exist cells that originate from the cerebral vesicle, as well as cells that develop from the 
olfactory placodes.  This difference is important because it identifies the cell types as 
being of central or peripheral origin.  It has been demonstrated that astrocytes, neurons, 
and oligodendroglia develop from the cerebral vesicle, while olfactory neurons and OECs 
are derived from the olfactory placodes (1).  In fact, OECs were originally known as 
olfactory nerve Schwann cells (SCs).  Thus, the peripheral nature of OECs is well 
established and their bridging function between the PNS and the CNS provokes questions 
regarding the true potential of these cells.   
However, the true characteristics of OECs are not limited to SC properties.  
Studies of OECs within the CNS demonstrate that they also have properties of astrocytes.   
For example, Devon et al demonstrated that OECs and astrocytes share the same 
anatomical location in the olfactory bulb, express glial fibrillary acidic protein (GFAP), 
and form the bulb’s glia limitans (4).  Because of the inability to categorize the OECs 
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based on astrocyte or SC characteristics alone, OECs were designated as their own glial 
cell type.  Furthermore, they are structurally distinct from other glial cells types with an 
electron rich cytoplasm, intermediate filaments, and irregular nuclei (3). 
OECs have multiple markers that allow for their identification, as pertaining to 
OEC extraction and purification.  The outer and inner layers of the olfactory nerve layer 
are distinguished by their reactivity with p75 and embryonic neural cell adhesion 
molecule (E-NCAM).  The OECs in the outer layer do demonstrate reactivity to the p75 
neurotrophin receptor and E-NCAM, while the OECs in the inner layer do not.  More 
generally, OECs in both layers have reactivity to S100 and green fibrillary acidic protein 
(GFAP).  S100 is a calcium binding protein that is associated with intracellular processes 
such as protein phosphorylation and differentiation and is considered to be a marker for 
SCs, astrocytes, and oligodendrocytes.  GFAP is an intermediate size cytoskeletal protein 
and is a marker for astrocytes (3).  OECs also express multiple trophic factors, 
transcription factors, and extracellular matrix molecules (5).   
Because the OECs are a specialized glial cell that have characteristics of 
astrocytes, SCs, and oligodendrocytes there has been extensive research regarding the 
potential of OECs to promote nerve regeneration when transplanted into the CNS.   
Several studies have demonstrated functional recovery after OEC transplantation in the 
injured CNS (5, 6, 7, 8, 9).  For example, in rats that have undergone complete spinal 
cord transection, transplantation of OECs results in recovered climbing ability and 
sensorimotor reflexes (3).  While the precise mechanism of this functional recovery is not 
fully understood, several mechanisms have been suggested including remyelination (4, 5, 
10, 11), long axon tract regeneration (7, 12, 13), axonal sparing (8) and plasticity 
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associated with novel polysynaptic pathways (14, 15).  In addition, recruitment of 
endogenous SCs (16, 17, 18) and remote inhibition of apoptosis of motor cortical neurons 
(19) have been suggested to contribute to improvement in functional outcome in injured 
CNS after OEC transplantation.  However, it is difficult to compare these studies given 
the variety of cell preparation and purification techniques, spinal cord injury methods, 
and OEC markers.   
The destruction of myelin in nervous system injury, both central and peripheral, is 
the target for regeneration research.  Peripheral myelin is formed by the plasma 
membrane of SCs as they wrap around axons and create multiple layers of wrapping 
mesaxon.  Central myelin is different in its formation and structure.  In the CNS myelin is 
also formed by oligodendrocytes, which also wrap their membrane around the axons.  
When oligodendrocytes form myelin in the CNS, each cell is responsible for myelination 
of multiple axons.  However, in the PNS, SCs only myelinate single axons.  This is a 
potential reason for why demyelinating disease in the CNS is more devastating to 
neurological function than demyelination and regeneration in the PNS (20).  Beyond 
myelination, the proper anatomical structure of the node of Ranvier, the paranodal region, 
and the juxtaparanode are essential for proper nerve conduction.  Within the node of 
Ranvier, sodium channels are clustered to allow for saltatory conduction.  The isoforms 
of these sodium channels can give clues as to the maturity of the node.  Adjacent to the 
node is the paranodal region where myelin is in direct contact with the axon.  Finally, 
adjacent to the paranodal region is the juxtaparanode.  
There is established data that demonstrates the ability of SCs to remyelinate areas 
of CNS injury.  In CNS injury there is a natural proliferation of SCs that originate in 
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dorsal roots and surround blood vessels that supply the spinal cord (21).  Thus, the 
natural presence of SCs within areas of CNS injury make them an interesting candidate 
for nerve repair.  What inhibits the benefit of SC transplantation is the presence of 
astrocytes within many CNS lesions, and these are thought to prevent SCs from migrating 
into the CNS.  Thus, in the presence of astrocytes, SCs do not thrive in CNS lesions.  
Because OECs share properties of both SCs and astrocytes, and also coexist with 
astrocytes in their native environment of the olfactory bulb, their potential therapeutic 
effect in CNS injury is intriguing (10).   
A study by Sasaki et al investigated the ability of OECs to form myelin within an 
area of spinal cord injury.  In adult rats, the dorsal funiculus was transected and OECs 
were transplanted into the lesion site.  It was demonstrated that five weeks after 
transplantation, the OECs survived within the lesion site, aligned longitudinally along the 
axon fibers, and did form peripheral type myelin.  However, there are other studies that 
have created similar models of OEC transplantation into spinal cord injury and believe 
that the myelin is formed by SCs that migrate into the lesion site from the periphery (5).  
The regeneration of peripheral type myelin in areas of spinal cord injury has been 
demonstrated to occur in the absence of OEC transplantation, thus supporting the theory 
of SC migration.  Therefore, it is difficult to differentiate between myelin that may have 
been formed by the transplanted OECs and that formed by endogenous SCs. 
Recently, it has been shown that after spinal cord remyelination by transplanted 
OECs derived from green fluorescent protein (GFP) expressing rats, nodes of Ranvier 
achieve sodium and potassium channel organization similar to that exhibited at mature 
central nodes.  A mature node of Ranvier is constructed such that sodium channels 
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populate the nodal area and potassium channels are located in the juxtaparanodal regions.  
Thus, in mature CNS nodes there exists a clustering of Nav1.6 at remyelinated nodes and 
Kv1.2 in the juxtaparanodal region (22).  Within an immature node the Nav1.2 isoform 
predominates.  As myelination occurs, Nav1.2 is replaced by Nav1.6, indicating node 
maturity (23).  It has been shown previously that engrafted GFP-expressing SCs 
participate in myelination of regenerated peripheral nerve fibers and that the Nav1.6 
sodium channel is reconstituted on the regenerated axons (24).  These results demonstrate 
that exogenous myelin-forming cells are able to contribute to the establishment and 
maintenance of mature ion channel distribution on remyelinated axons. Moreover, the 
remyelinated axons support rapid and secure impulse conduction after demyelination in 
the CNS.  
Although there is extensive, ongoing research on transplantation of OECs into the 
injured CNS, there are only limited studies regarding the role of transplanted OECs in the 
PNS.  The natural process of axonal degeneration that occurs after injury to the PNS is 
termed “Wallerian degeneration.”  Once peripheral nerve has been injured the distal 
nerve stump begins to degenerate.  Within 24-48 hours there occurs destruction of the 
myelin sheath, which is followed by fragmentation of the myelin into ellipsoids.  The 
ellipsoids divide such that one exists near the node of Ranvier and one in the internodal 
region.  Subsequently, there is a proliferation of SCs and invasion of macrophages.  The 
Wallerian degeneration that takes place in areas of CNS injury is different because there 
is no formation of ellipsoids or fragmentation of the internodal region.  Also in the CNS, 
myelin debris is removed by phagocytes and this proceeds at a slower rate than in the 
PNS (25).   
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After peripheral nervous system injury, the natural presence of SCs create an 
environment that allows axonal regeneration to occur.  For example, after a peripheral 
nerve injury, SCs will change their phenotype from a myelin forming cell to one that 
creates trophic factors, cell adhesion and extracellular matrix molecules, and the 
framework for axonal regeneration (26).  Eventually, axons in the peripheral nerve will 
sprout and grow towards distal targets and then be remyelinated by SCs from the distal 
stump (24).   
To investigate the myelin forming potential of OECs and their ability to compete 
with endogenous SCs in the PNS, OECs from adult GFP-expressing transgenic rats were 
transplanted into a crush lesion site in the sciatic nerve of non-GFP adult rat.  The study 
results demonstrate that GFP-OECs survive and distribute longitudinally along 
regenerated axons and remyelinated the injured axon after transplantation into injured 
peripheral nerve.  Furthermore, the regenerated fibers show reconstructed nodes of 
Ranvier with mature sodium channel organization. Thus, transplanted GFP-OECs 
prepared from adult rat olfactory bulb are able to remyelinate regenerated peripheral 









HYPOTHESIS AND STATEMENT OF PURPOSE 
 
Previous studies have demonstrated the myelin forming capacity of OECs when 
transplanted into areas of CNS injury.  Thus, we hypothesize that OECs will retain their 
myelin forming potential when transplanted into a peripheral nerve lesion.  We believe 
that OECs will allow for axonal regeneration and the formation of peripheral type myelin 
within the lesion site.  It is hypothesized that the OECs will migrate beyond the lesion 
site to induce guided axon regeneration.  Also, it is likely that the regenerated nodes of 
Ranvier will have proper ion channel structure, allowing for restoration of normal axon 
conduction velocity.  The primary purpose of this study is to investigate the myelin 
forming potential of OECs within the PNS.  This will lead to a better understanding of 
the basic characteristic of OECs and allow there to be confidence in previously published 












MATERIALS AND METHODS 
Contributions to the text for this section were made by Dr. Karen L. Lankford, Dr. 
Masanori Sasaki, Dr. Christine Radtke, and Dr. Jeffery Kocsis. 
 
Isolation and Characterization of Donor OECs 
Production of all reagents was performed by Dr. Karen L. Lankford. 
 To obtain freshly isolated OECs, olfactory bulbs were removed from 4 to 8 week-
old transgenic rats expressing GFP ["green rat" CZ-004, SD-Tg (Act-EGFP) CZ-004Osb; 
SLC, Shizuoka, Japan] and the meninges were removed to minimize contamination.   
After removing the caudal one-third of the bulb, the white matter was extracted and 
discarded to isolate the outer nerve layer.  Tissue was finely minced with a pair of scalpel 
blades (#10) on plastic culture dishes and incubated for 25 minutes in collagenase A (0.75 
mg/ml; Roche, Indianapolis, IN), collagenase D (0.75 mg/ml; Roche), and papain (12 
U/ml; Worthington, Lakewood, NJ) in calcium-free complete saline solution (CSS) with a 
trace of cysteine for 25 minutes at 37°C on a rotary shaker in a CO2 incubator.  The tissue 
suspension was then centrifuged for 7 minutes at 300 x g.   
Following this, the pellet was resuspended in 2 ml of Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Invitrogen, Carlsbad, CA) with 10% fetal calf serum (FCS) 
using gentle mechanical trituration with fire-polished pasture pipettes that had 
successively reduced diameters.  The volume of media was immediately increased to 20 
ml.  Undissociated pieces of tissue were allowed to settle for 2 minutes before 
transferring the cell suspension to another culture tube and centrifuging as before.  Cells 
were washed twice, resuspended, and preplated for 1 hour in a culture flask at 37°C in a 
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CO2 incubator.  Nonadherent cells were gently washed off with DMEM, and the cells 
were centrifuged and resuspended three times in DMEM.  Cells were counted and 
concentrated to 3.0 x 104 cells/µl just before transplantation.  P75- and S100-positive 
cells were counted in short-term cultures, made from cell suspensions used for 
transplantation, to assess purity of the cells.  Over 95% of the cells were positive for p75 
and S100.  
 
Crush Lesion and OEC transplantation 
Experiments were performed in accordance with the National Institutes of Health 
guidelines for the care and use of laboratory animals.  The Veterans Affairs Connecticut 
Healthcare System Institutional Animal Care and Use Committee approved all animal 
protocols.  Adult wild Sprague Dawley rats (200-225g) were used for this experiment 
(n=34).  The rats were first anesthetized with ketamine,75 mg/kg, intraperitoneally (i.p.) 
and xylazine, 10 mg/kg i.p.  The sciatic nerves were exposed near the piriformis tendon 
and crushed for 20 seconds with fine forceps (Dumont #5).  This procedure transects all 
of the axons in the nerve, but the epineurium remains intact, allowing the axons to 
regenerate into the distal nerve segment.  Immediately after the crush injury was 
performed, 0.5 μl of a GFP-OEC suspension (3.0 × 104 cells/μl), or DMEM for sham 
control, was injected just distally to the crush site using a glass pipette (40 μm tip 





Whole mount images of the living nerve 
Five weeks after transplantation, animals (n=3) were deeply anesthetized with 50 
mg/kg sodium pentobarbital i.p. and decapitated.  The sciatic nerve from transplanted rats 
was extracted and desheathed with fine forceps.  Some samples were put in 4% 
paraformaldehyde for five minutes and teased with fine forceps.  The sections were 
examined by conventional fluorescence microscopy (Nikon Eclipse 800; Spot RT Color 
CCD camera; Diagnostic Instruments). 
Immunohistochemistry. 
Immediately after the OECs had been prepared and isolated, they were 
resuspended in 10 ml of culture media.  They were then washed and plated in 8-well 
poly-L-lysine-coated chamber slides in DMEM with 10% FCS and penicillin–
streptomycin.  Cells were plated for 3-7 days and then fixed for 10 minutes in methanol 
that had previously been on ice.   The cells were then incubated in primary antibody 
overnight at 4oC.  The antibodies used were rabbit anti-p75 (1:1000; Chemicon, 
Temecula, CA), mouse monoclonal anti-S100 (1:1000; Chemicon), rabbit anti-cow S100 
(1:400; Dako, Carpinteria, CA), and mouse monoclonal anti-GFAP (1:1000, SMI22; 
Sternberger Monoclonals, Lutherville, MD).  Following this, cells were again incubated 
with Alexa Fluor 488 goat anti-mouse (1:1000; Molecular Probes, Eugene, OR) and 
Alexa Fluor 594 goat antirabbit (1:1000; Molecular Probes) and placed on a shaker at 
room temperature.  Cells were then counterstained on a shaker for one hour with Hoechst 
33358 (1:1000; Molecular Probes).  Images of the cells were taken with a Spot camera 
(Diagnostic Instruments, Sterling Heights, MI) and Spot Advanced software.  Finally, the 
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percent of OECs within the sample was determined using merged images of p75, S100, 
and GFAP with Hoechst nuclear stain. 
(The following immunohistochemistry was performed by Heather Mallozzi.) 
Sciatic nerves from the sham control (n=5), and GFP-OEC transplanted rats at 5 
weeks (n=20) and 6 months (n=3) following transplantation were processed for 
immunocytochemistry (27, 28).  Rats were deeply anesthetized with ketamine/xylazine 
and perfused transcardially, first with phosphate buffer saline (PBS) and then with ice-
cold 4% paraformaldehyde in 0.14 M Sorensen’s phosphate buffer, pH 7.4.  Sciatic 
nerves were excised and placed in fresh fixative to achieve a total fixation time of 25 
minutes.  Tissue was rinsed several times with PBS and cryoprotected in 30% sucrose in 
PBS overnight at 4°C.  Ten micrometer cryosections of the sciatic nerve were cut and 
mounted on glass (Fisher Superfrost Plus) slides.  The sections were processed for double 
immunofluorescent staining for the detection of Nav1.2, Nav1.6, and Caspr or with single 
immunolabeling for Neurofilament (NF).  The primary antibodies used were as follows: 
polyclonal Nav1.2 (1:100; Alomone Labs, Jerusalem, Israel), polyclonal Nav1.6 (1:100; 
Alomone Labs), monoclonal NF (1:1000; Sigma) and monoclonal Caspr (1:300) (29).  
Secondary antibodies used were as follows: goat anti-rabbit IgG-Cy3 (1:2000; Amersham 
Biosciences, Piscataway, NJ) and goat anti-mouse IgG-Alexa Fluor 633 or Alexa Fluor 
546 (1:1000; Invitrogen, Eugene, OR).  The sections were examined by confocal 
microscopy (Nikon Eclipse E600 microscope; Simple PCI; Compix Imaging Systems, 
Cranberry Township, PA) and with conventional fluorescence microscopy (Nikon Eclipse 
800; Spot RT Color CCD camera; Diagnostic Instruments). 
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Immunoelectron microscopy 
Seven weeks following transplantation, animals (n=3) were deeply anesthetized 
with 50 mg/kg sodium pentobarbital given i.p. and perfused transcardially with PBS.  
This was followed by 4% paraformaldehyde/0.02% glutaraldehyde in PBS.  Sciatic 
nerves were excised, postfixed overnight in 4% paraformaldehyde, and embedded in 3% 
agar for vibratome sectioning.  Free-floating sections that were 150 µm thick were 
incubated in 2% normal goat serum for 30 minutes and then in rabbit anti-GFP antibody 
(1:2000; Chemicon) overnight at 4°C.  These sections were then incubated overnight with 
an anti-rabbit biotinylated secondary antibody (Sigma, St. Louis, MO) and then incubated 
for 1 hour using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA) 
following standard protocols.  The sections were postfixed with 1% osmium tetroxide for 
4 hours, dehydrated in graded ethanol solutions and embedded in Epox-812 (Ernest 




Electrophysiological studies were performed by Dr. Hajime Tokuno. 
 Sections of host OEC transplanted sciatic nerve (1.5-3.0 cm) were removed and 
electrophysiology studies were performed.  The nerves were desheathed and placed in a 
nerve recording chamber.  The nerve recording chamber consists of 2 pairs of Ag-AgCl 
electrodes that were separated by 1 cm.  The nerve segments were placed across the 
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electrodes and the proximal nerve ending was stimulated.  At the distal end of the nerve 
segment the monophasic compound action potential was recorded.  Throughout the 
experiment, the central portion of the nerve segment was perfused with warmed (37oC) 
Ringer’s solution (30).   
When the proximal end of the nerve segment was electrically isolated, the peak of 
the action potential in response to a stimulus was recorded at varying distances.  The 
conduction velocity was determined by dividing the distance traveled by the onset or 
peak latency.  This provided an accurate measurement of conduction velocity in the 
regenerating nerve segment.  The electrophysiology studies were performed at 2, 3, 4, 7, 


























GFP-OECs transplanted into crushed sciatic nerve lesion 
Whole mount images of live and fixed nerve were prepared at five weeks post 
OEC transplantation and revealed that GFP-OECs survived in the lesion site and 
distributed longitudinally along the regenerated axons several millimeters from the 
injection site (Fig. 2A, 2B).  When the sciatic nerve was teased, it revealed that the GFP-
OECs were associated with individual axons within the lesion site (Fig. 2C1). Areas of 
intense fluorescence along the axon were detected and represent the dense cytoplasmic 
regions and nuclei of the GFP-OECs.  There were sections within the areas of 
concentrated fluorescence where no GFP fluorescence was detected and these areas were 
representative of putative nodes of Ranvier (Fig. 2C2).   Confocal images demonstrated 
an abundance of GFP-expressing OECs at the lesion site and they were oriented 
longitudinally along the nerve (Fig. 3A).   NF immunostaining images indicated the close 
association between the regenerated axon fibers and the GFP-expressing OECs (see inset 
Fig. 3A). 
Confocal images taken at six months post transplantation showed the presence of 
GFP-OECs indicated by intense green fluorescence (Fig. 3C).  In contrast to the results 5 
weeks following transplantation, the GFP intensity was slightly decreased. This 






Nav1.6 is located at the newly formed nodes of remyelinated axons 
Nodes of Ranvier within the GFP-OEC transplanted sciatic nerves were identified 
by flanking paranodal Caspr immunofluorescence (Fig. 3B) (22, 31, 32).  At 5 weeks 
after engraftment of OECs nodes were identified by their association with adjacent GFP-
OECs and Caspr reactivity. These areas were characterized by GFP fluorescence in the 
region of the terminal paranodal loops, as well as within the outer layer of the GFP-OEC 
sheath (Fig. 3B, inset upper right).  This confirms the association of the transplanted 
OECs with the remyelination of host axons.  Also, intense Nav1.6 was observed at the 
putative nodes of Ranvier (Fig. 3B inset lower left).  We observed Nav1.6 staining at most 
nodes, whereas detectable Nav1.2 immunostaining was not apparent at any nodes in the 
sciatic nerve (Fig. 5).  Similar results have been demonstrated in the CNS models of 
remyelinated lesion by transplanted GFP-OECs (22).  
Furthermore, 5 weeks after OEC engraftment in the PNS model, almost all nodes 
bounded by GFP-OEC myelin sheaths exhibited Nav1.6 staining (Fig. 5 A-D), while 
Nav1.2 immunolabeling was not observed at any nodes (Fig. 5 E-F).  The Nav1.6 labeling 
was limited to the nodal domain and was not observed in paranodal and juxtaparanodal 
regions or beneath the myelin sheath in remyelinated axons.  This suggests that the 
transplanted GFP-OECs are able to contribute to the specific clustering of sodium 





Immunoelectron microscopy of GFP-OECs forming myelin 
Immunoelectron microscopy for GFP-reaction product was performed to establish 
that the OECs derived from GFP rats were indeed responsible for the remyelination (Fig. 
6).  The cytoplasm and nuclei of cell profiles surrounding myelinated axons contained 
intense reaction product and GFP+ cells were determined to be in direct contact with host 
axons.  GFP-reaction product was clearly evident in the cytoplasm of most cells that 
formed the well defined multi-laminate structures characteristic of myelin.  In 
longitudinal sections of myelinated axons, intense reaction product can be seen in the 
cytoplasm of the myelin-forming cell (Fig. 6A1, 6A2).  The myelin formed has 
characteristics of peripheral type myelin given the large cytoplasmic and nuclear regions 
(Fig. 6B1).  Some unlabeled cells forming peripheral-like myelin could also be detected 
within transplanted lesions in the same areas as the labeled cells.  A limited number of 
GFP+ cells did surround host axons, but did not form myelin. 
 
Electrophysiology of transplanted sciatic nerve 
 Initial electrophysiological results of the transplanted sciatic nerve as compared to 
a normal control reveal greater than 50% recovery of nerve conduction velocity (Fig. 8).  
The compound action potential (CAP) of the sciatic nerve of normal controls was 44.8 
m/s.  Eight weeks after OEC transplantation, the conduction velocity of the sciatic nerve 
of the transplanted crushed nerve was 25.6 m/s.  Nerve conduction studies on crushed 
sciatic nerves without OEC transplantation were not performed.  We would expect 
remyelination to occur naturally and for there to be some level of nerve conduction 
restoration in this case, but not to the same extent as in the transplanted nerves. 
 18
 When electrophysiology studies were performed at more frequent intervals it was 
determined that at 2 weeks post GFP-OEC transplantation into the sciatic nerve crush 
injury there were no CAP observed.  However, at 3 weeks post transplant conduction 
velocity began to be restored.  Four weeks post transplant there was a reemergence of 
CAP signal.  By seven weeks post transplant it was observed that the peak latencies were 
shorter indicating faster conduction velocities, and at ten weeks post transplant there was 

































 There is much evidence regarding the potential of OECs to form myelin and to 
have beneficial effects within the context of CNS injury.  In a study by Sasaki et al 
transplantation of GFP-expressing rat OECs into a dorsal spinal cord transection lesion 
resulted in functional improvement and remyelination in a set of regenerated axons.  The 
dorsal funiculus of adult, female Sprague Dawley rats was transected and GFP expressing 
OECs were immediately transplanted into the lesion site via a micropipette injection 
technique.  The benefit of transplanting cells from a GFP transgenic rat is that the green 
fluorescence in the cytoplasm and nuclei of the transplanted cells makes them easy to 
identify in the host.  In the host rats, the new myelin that was formed contained GFP as 
confirmed by light microscopy and immunoelectron microscopy.  Thus, the transplanted 
OECs were confirmed to be the parent cell (19).     
Arguments regarding the true myelinating potential of OECs revolve around the 
idea that rather than actually forming new myelin, the transplanted OECs recruit SCs 
endogenous to the host which are responsible for the myelin formation.  The study did in 
fact identify cells within the lesion zone that were negative for GFP, but this was 
outweighed by the presence of GFP+ myelin.  Also, it is argued that the transplanted 
OECs could have been contaminated by SCs endogenous to the donor.   It is possible that 
there could be some amount of SC contamination due to the presence of SCs around 
vessels in the olfactory bulb, but the study states this would not account for the 
immunohistochemistry confirmed cell culture purity and the degree of myelin formation 
(5). 
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Previous work has demonstrated the ability of OECs to form myelin with a 
peripheral-like pattern when transplanted into a CNS lesion (5, 6, 10, 11, 22, 33, 34).   
The first in vivo study to demonstrate regrowth of peripheral type myelin in a CNS lesion 
was performed on injured, adult rat spinal cord.  In this study, clonal OECs were 
transplanted into an area of rat spinal cord that had been injured by X-irradiation and then 
injected with ethidium bromide.  The study demonstrated that the cells formed peripheral 
type myelin within the lesion site as indicated by the presence of P0 glycoprotein within 
the myelin sheaths (10).  In another study, this same method of spinal cord injury was 
performed and neonatal rat OECs were injected into the lesion site six days post injury.  
They studied the transplanted axons histologically and found that there were 
remyelinated axons near the lesion site and beyond.   Furthermore, to investigate the 
functional recovery electrophysiological studies were performed and revealed improved 
conduction velocity, as well as a greater distance of action potential conduction.  
Therefore, this supports the potential of OECs to remyelinate areas of spinal cord injury 
with resulting functional recovery (11). 
Limited research has been done on the regenerating and myelinating potential of 
OECs when transplanted into a PNS lesion.  It is well known that following peripheral 
nerve transection, axons in the proximal nerve region sprout and can regenerate toward 
peripheral targets, often leading to target reconnection (35).  Endogenous SCs, derived 
from the distal nerve segment, subsequently remyelinate these regenerated axons leading 
to rapid impulse conduction.  However, because OECs derived from GFP expressing rats 
were used, we could distinguish between transplanted and endogenous cells that 
contributed to the remyelination.   In one study the sciatic nerve of adult rats were 
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transected and the stumps were bridged with silicone tubing.  When OECs were added to 
the laminin gel filling the tubing it was found that axonal regeneration occurred in 50% 
of the rats.  Thus, it was determined that OECs promote nerve regeneration in severe 
peripheral nerve injury models (36).  Because the data on OEC transplantation into PNS 
injury are limited, it is important that this model be investigated regarding the myelin 
forming potential of the cells. 
 In this study, we demonstrate that when transplanted into a crush injury of the 
sciatic nerve of a rat host, GFP-expressing OECs survive and distribute longitudinally 
along regenerated axons.  NF staining reveals the regenerated axons to be surrounded by 
GFP fluorescence in the nuclei and dense cytoplasmic areas of the OECs.  Proper ion 
channel structure at the nodes of Ranvier in the regenerated axons was also evaluated.  In 
order to evaluate the distribution of ion channels in the regenerated axon, it is important 
to understand basic myelinated axon physiology.   
All myelinated axons are divided into distinct regions which include the node of 
Ranvier, the paranodal region, the juxtaparanodal region, and the internode.  Each region 
has a concentration of specific ion channel types and proteins.  The node of Ranvier 
consists of ~1-μm spaces in the myelin sheath where there exists a concentration of 
voltage gated sodium channel that allow for forward conduction through depolarization 
of the membrane (37).  Ten sodium channel isoforms have been identified in mammals 
and Nav1.6 is the dominant sodium channel at mature nodes (38).  The function of each 
sodium channel isoform has not yet been identified.  Nav1.1, Nav1.2, Nav1.3, and Nav1.6 
have been found to be expressed in the CNS, and Nav1.6 is found in nodes of Ranvier in 
both the CNS and PNS.   Thus, because this study demonstrated immunostaining of  
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Nav1.6 and lack of Nav1.2 in the transplanted hosts, it can be determined that mature 
nodes of Ranvier with proper sodium channel structure were formed.   
The paranodal region flanks the node of Ranvier and consist of cytoplasmic 
wrappings around the axon.  The paranodal junction, defined as the region between the 
node of Ranvier and the paranode, is characterized by the protein Caspr/Paranodin.  This 
region is multifunctional in that it allows myelin to be attached to the axon, as well as 
prevents both lateral and periaxonal diffusion (37).   
The juxtaparanodal region is defined as the area of axon that is beneath the end of 
the myelin sheath and is located just beyond the paranodal region.  This area is heavily 
populated by potassium channels, and their subtypes include Kv1.1, Kv1.2, Kv1.4 and 
Kvβ2.   The potassium channels are responsible for the repolarization of the axon, firing 
frequency, and neurotransmitter release (37,39).  Potassium channels are constructed of 
four α-subunits and 0-4 β–subunits.  There is a difference during development of the CNS 
and PNS regarding the location of potassium channels.  In the CNS the potassium 
channels are located in the juxtaparanodal region, whereas in the PNS, they begin at the 
node of Ranvier and then migrate out into the paranodal and juxtaparanodal regions (22). 
In the context of OEC transplantation into areas of CNS and PNS injury, it is 
important to evaluate whether or not the regenerated axon has proper ion channel 
structure to allow for restoration of normal conduction velocity.  In a study by Sasaki et 
al, it was demonstrated that when OECs were transplanted into an area of CNS injury that 
the nodes of Ranvier had correct sodium and potassium channel structure.  The new node 
was characterized as mature by the presence of Nav1.6 and the juxtaparanodal region 
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contained Kv1.2.  Most importantly this study revealed functional recovery as 
demonstrated by near normal conduction velocities at 3 weeks post transplant (22).   
 This study also showed clear evidence of GFP immuno-reactivity as seen on an 
ultrastructural level in the cytoplasm of cells within the lesion site that were forming 
peripheral-like myelin.  Myelin profiles, observed on an electron micrograph level, 
revealed a relatively high proportion of 3,3’-diaminodenzidine (DAB) positive cells 
associated with myelinated axon profiles.  Over half of the myelinated profiles were 
associated with GFP+ cells, providing similar results to that of the dorsal transection 
model in rat spinal cord (5).  Both endogenous SCs and transplanted OECs contribute to 
myelination of the regenerated axons. Taken together, it is concluded that within an area 
of peripheral nervous system injury, transplanted OECs can compete with endogenous 
SC and form new myelin on regenerated axons.   
 An important consideration in interpreting the results of the present study is the 
possibility that SC contamination in the OEC preparation might contribute significantly 
to the population of surviving cells in OEC transplanted lesions. As pointed out by Plant 
et al and further discussed by Boyd et al, SCs from nerves innervating blood vessels of 
the olfactory bulb may be a source of SC contamination in OEC preparations (8, 21).  
Although p75 and S100 staining can distinguish between OECs and other cell types 
within the olfactory bulb, they cannot distinguish between OECs and SCs.  While we 
cannot rule out the possibility of minor SC contamination in our OEC cultures, the 
comparable degree of SC and OEC integration into the transplanted nerve is incompatible 
with minor SC contamination in the OEC cultures (24).  Moreover, the extent of 
remyelination by equal numbers of transplanted genetically marked SCs and OECs was 
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similar in a spinal cord demyelination model.  This suggests that a small contaminant of 
SCs in the OEC preparation did not account for the remyelination by the transplanted 
OECs (40).    
Importantly, in a study by Franklin et al an immortalized OEC line was used for 
in vivo remyelination.  This further supports the idea that OECs are able to form myelin 
under appropriate conditions.  It was found that the OECs myelinated the axons in a 
manner similar to that of SCs.  The importance of using a clonal cell line for the OEC 
transplant was to ensure that the culture was not contaminated with phenotypically 
different cells (10).   However, it should be emphasized that the preparation of p75+ 
OECs from the adult olfactory bulb in the current study is diverse in culture and includes 
cells with flattened and spindled shapes that may have different fates in vivo.  
To further investigate the level of nerve repair after OEC transplantation, 
electrophysiology studies were performed.  Electrophysiology studies measured the 
conduction velocity of transplanted nerves, as compared to normal controls.  By 
electrically isolating one end of the nerve segment and then providing a stimulus, the 
amount of time required for the action potential to reach specific distances from the 
stimulus was recorded.  When analyzing the data, it is important to analyze the onset or 
peak latency.  Onset latency is defined as the time between the stimulus artifact and the 
beginning of the positive slope in the upswing of the plotted action potential.  The peak 
latency is defined as the time from the stimulus artifact to the highest point, the peak, 
where the slope of is zero.  To determine the conduction velocity the distance traveled is 
divided by the peak or onset latency.  In injured nerve, the conduction velocity is 
dramatically decreased, and as reinnervation and remyelination occur, the conduction 
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velocity is restored.  In our study it was determined that at 8 weeks post OEC transplant, 
the conduction velocity of the sciatic nerve segment studied was 25.6 m/s.  This is 
compared to the conduction velocity of the normal host sciatic nerve which was 
determined to be 44.8 m/s.   
The electrophysiology studies were subsequently repeated at more frequent 
intervals post OEC transplantation.  It was only at 3 weeks post transplantation that 
recovery of conduction velocity could be appreciated and at 4 weeks a reemergence of 
the CAP was seen.  Over time shortening of the peak latencies, and this increased 
conduction velocity, continued to be observed.  Further electrophysiology studies could 
include data on the conduction velocity of sciatic nerve with a crush injury and no 
transplantation of OECs.  This would provide a good comparison of the conduction 
velocity recovery in natural peripheral nerve remyelination to the faster recovery after 
OEC transplantation.  
These results indicate that transplanted OECs derived from adult rat olfactory 
bulb, myelinate regenerated peripheral nerve fibers and appropriate nodal sodium 
channels are formed on the remyelinated axons.  The extent of remyelination was similar 
to that reported for SC transplantation into the same model system suggesting that this 
unique population of cells within the olfactory bulb is capable of forming peripheral-like 
myelin (24).  While nerve regeneration is very successful in the nerve crush injury model 
without cell transplantation, following full transection with nerve reattachment functional 
outcome is more limited.  Given that transplantation of peripheral myelin-forming cells 
can integrate into peripheral nerve and contribute to repair, it will be important to 
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compare in the future the relative efficacy of SC and OEC transplants in nerve repair 
following engraftment into fully transected peripheral nerve.  
One concern in regards to OEC transplantation is the possibility that 
immunosuppression would be required for OEC survival.  In our study the host rats were 
not immunosupressed after the OEC transplant because the transplanted cells were from 
the same strain of Sprague-Dawley rat.  Although there is always a concern for rejection 
in allografts, especially when the transplanted cells contained a GFP transgene, rejection 
of the transplanted OECs was not encountered.   
Future research that will aide in the understanding of the potential of OECs to 
form myelin lies in the area of OEC identification.  Currently, OECs are identified by 
their expression of p75, S100, and GFAP.  However, these markers are also expressed by 
SCs, which makes it difficult to definitely assess the purity of OEC cultures.   It is also 
argued that without a marker specific to OECs, it cannot be concluded that OECs 
transform into SC like cells that form peripheral type myelin when transplanted into an 
area of CNS injury.  Because the natural attempt at repair of CNS injury involves 
migration of SCs into the lesion, the host’s SCs and the transplanted OECs cannot be 
differentiated (41).    
A new controversial marker, calponin, has recently been proposed to distinguish 
phenotypically OECs and SCs.  Calponin is an actin binding protein that plays a role in 
smooth muscle contraction and it is not found in SCs (42).    In a study by Rizek et al, it 
was determined that fetal rat bulbar OECs express calponin and SCs from adult rat sciatic 
nerve do not (41).  However, there are some studies that do not support this conclusion.  
In a study by Ibanez et al the expression of calponin by adult OECs was examined both in 
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vivo and in vitro.  It was determined that calponin was associated with fibronectin 
positive fibroblasts in the olfactory mucosa and olfactory bulb meningeal cells.  
However, it was not associated with expression of S100 or neuropeptide Y positive 
OECs.  In vitro, the fibronectin expressing fibroblasts and meningeal cell expression was 
the same.  Calponin was not associated with p75 and S100 expressing OECs in vitro (43).  
Determining the contribution of calponin to the identification of OECs would be a crucial 
next step in experimentation and could allow further identification of transplanted OECs 
in PNS injury models.   If calponin proves to be a marker for OECs, the purity of OEC 
cultures used for transplantation could be assessed.  Future studies would be able to 
determine with certainty that OECs are solely responsible for the formation of peripheral 
type myelin when transplanted into an area of peripheral nerve injury. 
Autologous transplantation of OECs into humans with spinal cord injury is the 
next step in applications of this research.  Currently, multiple studies have been 
performed assessing the safety and efficacy of autologous OEC transplant.  Questions 
exist regarding the best source of OECs for transplantation, how well the cells will 
survive in the lesion site, if they will migrate beyond the lesion site, and if there will be 
any functional improvement in patients over time.  A study by Feron et al investigated the 
safety of OEC transplant in humans with spinal cord injury at the thoracic level.  This 
was a single, blind Phase I clinical trial and the hosts were three men, aged 18-55.  The 
participants were rigorously screened for psychosocial stability, with the hope that they 
would be amenable to study follow up for at least three years.  OECs used for transplant 
were retrieved by biopsy of the patients’ nasal septum near the cribiform plate and then 
purified and cultured in vitro.  This study reported that up to one year post transplant, the 
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patients reported having no neuropathic pain and were assessed to have no change in 
neurological or psychosocial status.  Furthermore, MRI data at one year post transplant 
indicated no overgrowth of transplanted cells and no evidence of syringomyelia (44).  
This study supports the idea that autologous OEC transplantation in humans is feasible 
and the current data supports its safety. 
Questions exist regarding the survival of human OECs when transplanted into 
areas of spinal cord injury.  Deng et al investigated this issue by separately transplanting 
OECs from both rats and humans into the spinal cord of athymic rats.  The 
immunodeficiency of the rats allowed for analysis of human OECs within the rat model.   
The study indicated that after transplantation, both human and rat OECs quickly stopped 
dividing and showed similar abilities to survive and migrate in the host.  This study gives 
confidence to the use of OECs in human spinal cord injury (45).  Also, because OECs can 
be obtained from the human nasal epithelium, simple biopsy could be used to obtain cells 
for autologous transplantation, thus eliminating the need for immunosuppression. 
Another method of obtaining human OECs for transplantation is from human 
cadaver donors.  While obtaining OECs from nasal mucosa biopsy for autologous 
transplants is under investigation, the recovery of OECs from the olfactory bulbs and 
olfactory mucosa of adult, cadaver donors is another cell source.  A study by 
Miedzybrodzki et al determined that OEC culture after up to 20 minutes of warm 
ischemia time was successful (n=10).   Secondly, in seven cases, OECs were retrieved 
from cadaver olfactory mucosa and this was determined to be a more reliable source of 
cells (46).  Thus, although immunosuppression would be an issue for cadaver OEC 
transplantation, this source remains a viable option. 
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There is controversy in the literature regarding reports of successful OEC 
transplantation in humans.  One researcher has been particularly aggressive in 
transplantation in humans and has performed greater than 400 OEC transplants in patients 
with spinal cord injury.  The OECs used for transplant were derived from aborted fetuses.  
Dobkin et al studied seven of these patients with chronic spinal cord injury to assess for 
functional recovery and safety of this experiment.  It is reported that the method is not 
safe or efficacious.   Furthermore, of the seven patients studied, five were reported to 
suffer complications such as meningitis, and none of the patients studied had any 
clinically significant functional recovery (47).  Therefore, this study indicates that while 
the data on OEC transplantation is vast and expanding, there are more questions to be 
answered before OEC transplantation in humans can become standard therapy. 
Results of the current study reveal that at five weeks post transplantation the 
OECs survived within the lesion site, oriented longitudinally along the transection zone, 
and that peripheral type myelin expressing GFP was present.   Furthermore, regenerated 
nodes of Ranvier demonstrated mature structure with proper sodium channel distribution.  
Nerve conduction studies revealed restoration of conduction velocity, and this has great 
implications for functional recovery of the hosts.  This data allows for there to be 
confidence in the current data on OEC transplantation into CNS injury, since the 
properties of OECs have been elucidated and their value to the field of nerve regeneration 









Images produced by Dr. Karen L. Lankford.   




Olfactory ensheathing cells in culture with Hoechst nuclear staining 
 
The OECs were stained for p75 (A), S100 (B), and GFAP (D).  Merged images of 
S100 (C) and GFAP (D) immunostaining with p75 indicated extensive co-localization.  
Greater than 95% of cells were p75 and S100 positive.  (F) represents a control section 







Olfactory ensheathing cell (OEC) transplantation into crushed sciatic nerve 
Fluorescent images of living sciatic nerve whole mount taken immediately upon 
extraction and desheathment (A), and fixed nerve at 5 weeks post transplantation (B). 
Green fluorescent protein (GFP)-OECs are distributed longitudinally several millimeters 
from the injection site.  Areas of increased fluorescence indicate the nuclei and dense 
cytoplasmic regions of the OECs.  Higher magnification image of teased, fixed nerve 
taken immediately upon removal at 5 weeks post transplantation (C1).  GFP-OECs 
associate with individual axons within the lesion site.  An individual living axon with 
putative nodes of Ranvier (boxed) and areas of concentrated fluorescence, which indicate 
OEC nuclei and cytoplasm (C2).    
Scale bar: A=500µm, B = 25µm, C1= 11µm, C2=3.5µm 
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Figure 3 
Image A taken by Mary Dombrowski.  Image B and C taken by Dr. Masanori Sasaki. 
 
 
Confocal images at 5 weeks and 6 months post OEC transplantation 
 of the crushed sciatic nerve. 
This image demonstrates an abundance of GFP-OECs distributed longitudinally 
in the injured nerve (A).  Association of GFP fluorescence with axonal neurofilament 
staining (Inset A).  Caspr immunostaining demonstrates GFP-OECs in the transplanted 
region and the inset in the upper right is a higher magnification of individual nodal 
regions (B). Immunostaining for sodium channel Nav1.6 reveals nodal regions within the 
crush lesion site (B).  Six months post crush injury and transplantation the GFP-OECs do 
survive (C).  





Neurofilament staining four weeks post GFP-OEC transplantation 
 
These images demonstrate GFP immunofluorescence four weeks post GFP-OEC 
transplantation into the sciatic nerve crush injury (A, D).  Immunostaining for 
neurofilament (NF) of the same field (B, E).  Merged images show GFP fluorescence 
surrounding the NF stained axon (C,F).   











Images taken by Dr. Masanori Sasaki. 
 
 
Nav1.2 and Nav1.6 at GFP-OEC nodes in crushed sciatic nerve 
 
At 5 weeks after transplantation, Caspr immunostaining flanks the node of 
Ranvier (A) formed by GFP-OECs (C).  Nav1.6 clustering is displayed at most Caspr-
delimited nodes (B).   In contrast, Nav1.2 is not seen, indicating node maturity (F).  GFP-
OECs at 5 weeks post transplant (G) and corresponding Caspr immunostaining (E). 
Merged images of (A–C) and (E–G) are shown in (D) and (H), respectively.  






Images taken by Dr. Masanori Sasaki. 
 
 
Electron micrographs of anti-GFP immunoperoxidase staining 
 
At 7 weeks post transplantation reaction product can be seen in the cytoplasm of 
the GFP-OECs, which have formed myelin around an axon (A1).  Higher magnification 
of boxed area in A1 (A2).  Another myelinated axon showing intense reaction product in 
the myelin forming cell (B1).  Higher magnification of boxed area in B1 (B2). 







Images taken and modified by Dr. Masanori Sasaki (5). 
 
Electron micrograph images of transplanted sciatic nerve with 
anti-GFP immunoperoxidase 
    
Reaction product for anti-GFP is seen  in the cytoplasm of myelin forming cells, 
but not directly in the myelin (A1).  In this same figure a myelinated axon  not containing 
any reaction product is also seen.  The boxed area of A1 (A2).  An axonal cross section 
demonstrates cytoplasmic reaction product (B1).  The boxed area of B1 (B2). 




Images produced by Dr. Hajime Tokuno. 
 
 
Electrophysiology studies of sciatic nerve segment 8 weeks post  
GFP-OEC transplant 
 
The figure on the left represents the compound action potentials (CAP) of the 
sciatic nerve of normal control animals.  The figure on the right represents the CAPs of 
transplanted hosts eight weeks following OEC transplantation.  The conduction velocity 
of the normal, control nerve was 44.8 m/s, while the conduction velocity of the crushed 




Electrophysiology studies of GFP-OEC transplanted sciatic nerve 
at varying time intervals 
Compound action potential (CAP) at a specific distance away from the stimulus 
electrode (A, B).  Dashed lines indicate peak negativity of CAP.  It can be determined 
that at four weeks post sciatic nerve injury and OEC transplantation, the CAP signal 
returns.  At seven weeks post sciatic nerve injury and OEC transplantation, there is 
shortening of the peak latencies and improvement in the CAP amplitude over a greater 
distance (B).  Over 10 weeks increasing conduction velocity was observed (n=4 per 
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